In last trading session, Applied DNA Sciences, Inc. (NASDAQ:APDN) saw 2,201,525 shares changing hands with its beta currently measuring 1.01. Company’s recent per share price level of $9.28 trading at $1.66 or 21.78% at ring of the bell on the day assigns it a market valuation of $43.41 Million. That closing price of APDN’s stock is at a discount of -150% from its 52-week high price of $23.2 and is indicating a premium of 72.84% from its 52-week low price of $2.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 467.5 Million shares which gives us an average trading volume of 1.92 Million if we extend that period to 3-months.

For Applied DNA Sciences, Inc. (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.73 in the current quarter.

Applied DNA Sciences, Inc. (NASDAQ:APDN) trade information

Upright in the green today for gaining 21.78%, in the last five days APDN remained trading in the green while hitting it’s week-highest on Thursday, Jun 25 when the stock touched $9.50-2 price level, adding 2.32% to its value on the day. Applied DNA Sciences, Inc.’s shares saw a change of 121.48% in year-to-date performance and have moved 26.95% in past 5-day. Applied DNA Sciences, Inc. (NASDAQ:APDN) showed a performance of -15.94% in past 30-days. Number of shares sold short was 346Million shares which calculate 180.21 days to cover the short interests.

Applied DNA Sciences, Inc. (APDN) estimates and forecasts

Statistics highlight that Applied DNA Sciences, Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company added +137.34% of value to its shares in past 6 months, showing an annual growth rate of NA% while that of industry is NA. Apart from that, the company came raising its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to increase by 54.4% in the current quarter and calculating 86.7% increase in the next quarter. This year revenue growth is estimated to drop -9.3% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $1.1 Million for the same. And 1 analysts are in estimates of company making revenue of $2.6 Million in the next quarter that will end in September 01, 2020. Company posted $2.05 Million and $1.67 Million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to drop by -46.4% while estimating it to be 55.4% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 24.2% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 38.9% while estimates for its earnings growth in next 5 years are of 0%